Bosaya Purple Book BLA 761436

BLA number
761436
Proprietary names
Bosaya, Aukelso
Proper names
denosumab-kyqq
Applicant
Biocon Biologics Inc.
Center
CDER
First observed release
2025-09-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Bosayadenosumab-kyqq351(k) Interchangeable60MG/MLInjectionSubcutaneousPre-Filled SyringeRxLicensed2025-09-16
002Aukelsodenosumab-kyqq351(k) Interchangeable120MG/1.7ML (70MG/ML)InjectionSubcutaneousSingle-Dose VialRxLicensed2025-09-16

Reference Biological Product#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125320Proliadenosumab351(a)Rx2026-06-01

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2025-11-01U001Bosaya351(k) InterchangeableRxBiocon Biologics Inc.
2025-11-01U002Aukelso351(k) InterchangeableRxBiocon Biologics Inc.
2025-09-01N001Bosaya351(k) BiosimilarRxBiocon Biologics Inc.
2025-09-01N002Aukelso351(k) BiosimilarRxBiocon Biologics Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2025-11-01001Bosaya351(k) InterchangeableRxLicensed2025-09-16
2025-11-01002Aukelso351(k) InterchangeableRxLicensed2025-09-16
2025-09-01001Bosaya351(k) BiosimilarRxLicensed2025-09-16
2025-09-01002Aukelso351(k) BiosimilarRxLicensed2025-09-16